# AN2 Therapeutics (ANTX) — Earnings

ANTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/antx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.21 |
| EPS estimate | −$0.34 |
| EPS surprise | +37.31% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1880438/000095017025107301/antx-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$0.34 | −$0.21 | 37.31% | — | — |
| Q1 2025 | May 13, 2025 | −$0.27 | −$0.35 | -32.08% | — | — |
| Q4 2024 | Mar 25, 2025 | −$0.27 | −$0.25 | 7.41% | — | — |
| Q3 2024 | Nov 13, 2024 | −$0.45 | −$0.43 | 4.44% | — | — |
| Q2 2024 | Aug 13, 2024 | −$0.61 | −$0.48 | 20.79% | — | — |
| Q1 2024 | May 14, 2024 | −$0.62 | −$0.56 | 9.68% | — | — |
| Q4 2023 | Mar 28, 2024 | −$0.74 | −$0.57 | 22.55% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.65 | −$0.65 | -0.39% | — | — |
| Q2 2023 | Aug 10, 2023 | −$0.85 | −$0.81 | 4.99% | — | — |
| Q1 2023 | May 11, 2023 | −$0.66 | −$0.79 | -20.15% | — | — |
| Q4 2022 | Mar 29, 2023 | −$0.63 | −$0.61 | 3.56% | — | — |
| Q3 2022 | Nov 9, 2022 | −$0.59 | −$0.59 | 0.42% | — | — |
| Q2 2022 | Aug 11, 2022 | −$1.54 | −$0.53 | 65.53% | — | — |
| Q1 2022 | May 10, 2022 | −$0.93 | −$2.98 | -220.43% | — | — |

## Frequently Asked Questions

### When did AN2 Therapeutics (ANTX) last report earnings?

AN2 Therapeutics last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did ANTX beat earnings estimates?

Yes. AN2 Therapeutics reported EPS of −$0.21 for Q2 2025 against a −$0.34 estimate — a 37.31% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).